EJPT announces a Call for Papers on: Neurobiology of PTSD – where do we stand?
Guest Editor: Dr. Ulrike Schmidt, Max-Planck-Institute of Psychiatry, Germany
Current treatment options for the torturing symptoms of posttraumatic stress disorder (PTSD) are limited: A significant proportion of patients do not benefit sufficiently from exposure-based psychotherapy and, moreover, only about one third of PTSD patients treated with the first-line pharmacotherapy achieve full remission. Together with this dissatisfying treatment situation, the lack of clinical markers for PTSD urges the need for further elucidation of its biological basis.
In the last decades, researchers have addressed the neuropsychobiological underpinnings of PTSD with clinical, animal and translational studies. Despite the fragmentary state of knowledge, some findings regarding PTSD neurobiology are generally accepted, for instance the association of PTSD with dysregulation of hypothalamic-pituitary-adrenal (HPA)-axis and of the sympathetic nervous system, with hippocampal volume loss and with dysfunction of distinct cortical areas. However, the questions remains, which facets of these findings are specific for PTSD. Moreover, studies in animals and in humans convincingly demonstrated that genetic, epigenetic and environmental factors interact to modulate the individual risk to develop PTSD in the aftermath of a traumatic event.
This special issue on the topic “Neurobiology of PTSD – where do we stand?” aims to, first, give an overview of the state of research on neurobiology of PTSD, second, to publish recent cutting-edge findings on PTSD pathobiology and, third, to stimulate the discussion of what we can do in the future to bridge the translational gap in PTSD research.
European Journal of Psychotraumatology now invites original research papers and systematic review articles as well as debate pieces and short communications on the following topics:
- Imaging and any type of molecular (i.e. genetic, epigenetic, proteomic) studies on PTSD patients and/or on traumatized healthy individuals
- Studies on the neurobiology of PTSD-like symptoms in animal models
- Pharmacological studies: clinical pharmacological studies in PTSD patients and in animal models for PTSD
- Molecular biology studies aiming to analyze either the regulation or the function of PTSD candidate molecules (e.g. FKBP5, PACAP, GR)
How to submit: Please go to the website of the journal www.ejpt.net, read the author instructions carefully and then click the “Submit a manuscript” button in the upper right-hand corner and follow the instructions. The section to select is “Neurobiology of PTSD – where do we stand?”
Regular publication fee applies; please see http://www.ejpt.net/index.php/ejpt/pages/view/fee.
Timeline: The submission deadline is February 1, 2016. A first round of reviews is expected four weeks after submission at the latest.